[HTML][HTML] Brucellosis: Evolution and expected comeback

A El-Sayed, W Awad - International journal of veterinary science and …, 2018 - Elsevier
Brucellosis is a serious infectious disease which causes great direct and indirect economic
loses for animal holders worldwide such as the reduction of milk and meat production …

[HTML][HTML] Prophylactic vaccine delivery systems against epidemic infectious diseases

C Pan, H Yue, L Zhu, G Ma, H Wang - Advanced drug delivery reviews, 2021 - Elsevier
Prophylactic vaccines have evolved from traditional whole-cell vaccines to safer subunit
vaccines. However, subunit vaccines still face problems, such as poor immunogenicity and …

A cutting-edge immunoinformatics approach for design of multi-epitope oral vaccine against dreadful human malaria

M Pritam, G Singh, S Swaroop, AK Singh… - International Journal of …, 2020 - Elsevier
Human malaria is a pathogenic disease mainly caused by Plasmodium falciparum, which
was responsible for about 405,000 deaths globally in the year 2018. To date, several …

Development of a novel multi-epitope vaccine for brucellosis prevention

K Shang, Y Zhu, T Tian, H Shi, Z Yin, Y He, J Shi… - Heliyon, 2024 - cell.com
Brucellosis, a zoonotic disease caused by Brucella, presents a significant threat to both
animal and human health. In animals, the disease can lead to infertility, miscarriage, and …

Expression and purification of TolC as a recombinant protein vaccine against Shigella flexneri and evaluation of immunogenic response in mice

R Veisi, S Nazarian, J Fathi, N Hadi - Microbial Pathogenesis, 2024 - Elsevier
Background Shigella is one of the major causes of dysenteric diarrhea, which is known
shigelosis. Shigelosis causes 160,000 deaths annually of diarrheal disease in the global …

Identification and evaluation of novel vaccine candidates against Shigella flexneri through reverse vaccinology approach

A Hajialibeigi, J Amani, SLM Gargari - Applied Microbiology and …, 2021 - Springer
Shigellosis is a significant type of diarrhea that causes 160,000 deaths annually in a global
scale. The mortality occurs mainly in children less than 5 years of age. No licensed vaccine …

High protection of mice against Brucella abortus by oral immunization with recombinant probiotic Lactobacillus casei vector vaccine, expressing the outer membrane …

E Mohammadi, M Golchin - Comparative immunology, microbiology and …, 2020 - Elsevier
Brucellosis is a zoonotic disease threatening the public health and hindering the trade of
animals and their products, which has a negative impact on the economic development of a …

Application of an O-Linked Glycosylation System in Yersinia enterocolitica Serotype O:9 to Generate a New Candidate Vaccine against Brucella abortus

J Huang, C Pan, P Sun, E Feng, J Wu, L Zhu, H Wang - Microorganisms, 2020 - mdpi.com
Brucellosis is a major zoonotic public health threat worldwide, causing veterinary morbidity
and major economic losses in endemic regions. However, no efficacious brucellosis vaccine …

[HTML][HTML] Biosynthesis and immunological evaluation of a dual-antigen nanoconjugate vaccine against Brucella melitensis

J Huang, Y Wang, K Wang, S Li, P Sun, Y Guo, J Liu… - Engineering, 2023 - Elsevier
Brucellosis, caused by Brucella, is one of the most common zoonosis. However, there is still
no vaccine for human use. Although some live attenuated vaccines have been approved for …

Identification and design of a next-generation multi epitopes bases peptide vaccine candidate against prostate cancer: an in silico approach

P Patra, M Bhattacharya, AR Sharma, P Ghosh… - Cell Biochemistry and …, 2020 - Springer
Prostate cancer (PCa) is the second most diagnosed cancer in men and ranked fifth in
overall cancer diagnosis. During the past decades, it has arisen as a significant life …